Evidence map›Paper›PMID 27141276›Full record

ReviewIranian journal of neurology2016

Myotonic disorders: A review article.

Chris Hahn, Mohammad Kian Salajegheh

Open access · greenAbstract readReview
In one paragraph

Review in Iranian journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pain and Motor Function in Myotonic Dystrophy Type 1: A Cross-Sectional Study.International journal of environmental research and public health · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Myotonic disorders and pregnancy.Obstetric medicine · 2020
    Review
  10. Frontiers in neurology · 2020
    Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. An Unusual Case of Hybrid Odontogenic Tumor in Type 1 Myotonic Dystrophy Patient.International journal of applied & basic medical research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Chris HahnDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Mohammad Kian SalajeghehDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Brigham and Women's Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The myotonic disorders are a heterogeneous group of genetically determined diseases that are unified by the presence of myotonia, which is defined as failure of muscle relaxation after activation. The presentation of these disorders can range from asymptomatic electrical myotonia, as seen in some forms of myotonia congenita (MC), to severe disability with muscle weakness, cardiac conduction defects, and other systemic features as in myotonic dystrophy type I (DM1). In this review, we describe the clinical features and pathophysiology of the different myotonic disorders, their laboratory and electrophysiologic findings and briefly review the currently available treatments.

Indexed as

Hyperkalemic Periodic ParalysisMyotoniaMyotonia CongenitaMyotonic DystrophyParalysis Periodica Paramyotonia

Identifiers

PMID27141276
PMCPMC4852070
OpenAlexW2226574669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.